SciFounders
VC Fund
San Francisco, United States
SciFounders is a VC fund in San Francisco focused on Health Care and Biotechnology. Helping science companies get started. We invest in technical startups from idea stage to Series A. We start companies too.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 29%
- Fund size:
- $2.5M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries SciFounders invests in
Stages SciFounders invests in
Countries SciFounders invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $3.2M–$5M
- Pre-Seed
- $400k–$400k
- Series A
- $2.5M–$21M
Investment Focus
Industry
- Health Care 6 (43%)
- Biotechnology 5 (36%)
- Medical 4 (29%)
- Therapeutics 3 (21%)
- Medical Device 3 (21%)
Stage
- Seed 5 (36%)
- Pre-Seed 5 (36%)
- Series A 1 (7%)
- Funding Round 1 (7%)
Country
- United States 6 (43%)
- Ireland 1 (7%)
- United Kingdom 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Alexander Schubert
Co-Founder and Partner
|
Co-Founder and Partner | Total investments: 0 | Find email | |
Lucas Harrington
Co-founder
|
Co-founder | Total investments: 0 | Find email | |
Matthew Krisiloff
Partner and Co-Founder
|
Partner and Co-Founder | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Luminate is an oncology-focused healthtech and tech-enabled services company that partners with payers, providers, and people with cancer to reduce the cost of cancer care while improving quality of life and outcomes for patients. The company offers a portfolio of services and technologies that enable home-based cancer treatment, adverse eventmonitoring, and prevention of drug-induced side effects. | $21M / Series A / Jan 07, 2026 | ||
| Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions. | Mar 19, 2025 | ||
| Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions. | $4.5M / Seed / Mar 19, 2025 | ||
| Luminate is an oncology-focused healthtech and tech-enabled services company that partners with payers, providers, and people with cancer to reduce the cost of cancer care while improving quality of life and outcomes for patients. The company offers a portfolio of services and technologies that enable home-based cancer treatment, adverse eventmonitoring, and prevention of drug-induced side effects. | $2.5M / Series A / Dec 04, 2024 | ||
| Current Surgical is a surgical device company that develops precise tools for the treatment of solid tumors. The company was founded in 2020 and has its headquarters in Washington, DC. | $3.2M / Seed / Feb 21, 2023 | ||
| Current Surgical is a surgical device company that develops precise tools for the treatment of solid tumors. The company was founded in 2020 and has its headquarters in Washington, DC. | Seed / Feb 21, 2023 | ||
| Luminate is an oncology-focused healthtech and tech-enabled services company that partners with payers, providers, and people with cancer to reduce the cost of cancer care while improving quality of life and outcomes for patients. The company offers a portfolio of services and technologies that enable home-based cancer treatment, adverse eventmonitoring, and prevention of drug-induced side effects. | $5M / Seed / May 30, 2022 | ||
| mRNA immunotherapies to defeat cancer | $3.9M / Seed / May 01, 2022 | ||
| ImmTune Therapies is an operator of a cell therapy process intended to cut out complicated biomanufacturing processes. The company's platform brings cell therapies to many, enabling patients to enjoy a reduction in the costs of treatment, which were previously a burden on patients. | Seed / May 01, 2022 | ||
| Inherent Targeting develops fluorescent contrast agents that target nerves to improve surgical outcomes. The company was founded in 2019 and is headquartered in Portland, Oregon. | Pre-Seed / Dec 01, 2021 | ||
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does SciFounders invest in?
SciFounders invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Pre-Seed stage. Most of the 14 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does SciFounders invest in?
SciFounders typically joins rounds of $3.2M–$5M at Seed, $400k–$400k at Pre-Seed and $2.5M–$21M at Series A. These are whole funding-round sizes, not SciFounders's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds SciFounders took part in.
How do I contact SciFounders?
Public channels for SciFounders include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at SciFounders?
The team at SciFounders includes Alexander Schubert (Co-Founder and Partner), Lucas Harrington (Co-founder) and Matthew Krisiloff (Partner and Co-Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
